Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Belantamab Mafodotin in Patients With Relapsed/Refractory Multiple Myeloma and Severe Renal Impairment (Including Dialysis): Results From the Phase I DREAMM-12 Study
Sosana Delimpasi, Xialin Chen, Yi Ting Lien, Shawn Hakim, M. Arning, Esther Hrabrick, Astrid McKeown, Swapna Ghanta, Meletios A Dimopoulos, Eben I. Lichtman, Chang‐Ki Min, Wee Joo Chng, Sikander Ailawadhi, Geraldine Ferron‐Brady (2025). Belantamab Mafodotin in Patients With Relapsed/Refractory Multiple Myeloma and Severe Renal Impairment (Including Dialysis): Results From the Phase I DREAMM-12 Study. , 25, DOI: https://doi.org/10.1016/s2152-2650(25)03963-1.
Article32 days agoBelantamab Mafodotin in Patients With Relapsed/Refractory Multiple Myeloma and Severe Renal Impairment (Including Dialysis): Results From the Phase I DREAMM-12 Study
Sosana Delimpasi, Xialin Chen, Yi Ting Lien, Shawn Hakim, M. Arning, Esther Hrabrick, Astrid McKeown, Swapna Ghanta, Meletios A Dimopoulos, Eben I. Lichtman, Chang‐Ki Min, Wee Joo Chng, Sikander Ailawadhi, Geraldine Ferron‐Brady (2025). Belantamab Mafodotin in Patients With Relapsed/Refractory Multiple Myeloma and Severe Renal Impairment (Including Dialysis): Results From the Phase I DREAMM-12 Study. , 25, DOI: https://doi.org/10.1016/s2152-2650(25)03963-1.
Article32 days ago